New VC firm seeks start-ups who are working to solve the “urgent problems” facing today’s aging society.
This summer, a new venture capital firm was...
AgeTech Accelerator's Lorraine Morley on market disconnect, helping investors take the plunge and shaping the AgeTech market.
Continuing our series of interviews with our Advisory Panel...
Company spawned by London start-up generator targets middle-aged recreational athletes with exoskeleton leggings powered by soft robotics.
Back in November, we brought you the story...
We talk with VC investor Forte Ventures about its first foray into AgeTech, COVID-19 and the Longevity investment opportunity.
Longevity agetech company K4Connect has announced...
K4Connect aims to create a smart OS for senior living with a single interface for all technologies.
Technology adoption among older adults has been consistently...
VirtuSense uses machine vision and AI to address the multi-million falls prevention market opportunity.
According to the U.S. Centers for Disease Control and Prevention, falls...
Virtuleap currently fundraising to build headcount and capitalise on cognitive illness detection algorithms.
Ever since the US Federal Trade Commission fined Lumosity $2 million for...
Aging2.0 announces inaugural VOLTAGE event, connecting entrepreneurs and innovators to build a single market for active and healthy aging in Europe.
This April, Aging2.0 will...
Cambridge Brain Sciences brings cognitive function assessment into the 21st century - as biomarkers become more integrated with Longevity cognition is key.
Monitoring and assessing...
Addressing the root cause of caregiver burnout before it happens is becoming an imperative as health systems struggle with growing numbers of older people...
Singapore thrives on its prime location at the crossroads of Asia's biggest markets, low business tax and great IT infrastructure; it is well-positioned to...
Grant-funded AI start-up CUSH Health targets falls that cost the NHS £2 billion annually.
The impact of falls on the elderly population is significant. In...
Recent study identifies critical regulator of protein biosynthesis recovery and homeostasis required for Longevity.
Unresolved DNA damage caused by intrinsic and environmental factors accumulates during...
Start the clock to stop the clock – centralised data will aid Longevity research.
Deep Longevity, which engages in the development of explainable AI systems...
Tracked.bio develops AI computer vision system that tracks flies and mice to reduce man-hours and increase data collected in Longevity studies.
A Danish start-up aims...
Following an R&D collaboration that began last year, Japanese pharma Astellas has announced it will acquire bioelectronics firm iota in $304m deal.
Last year's R&D...
![Ozone therapy recently hit the headlines as one of the many treatment options being examined to mitigate the effects of COVID-19 [1], but it is also showing great promise in the treatment of neurodegenerative conditions such as Alzheimer’s and Parkinson's.](https://www.longevity.technology/wp-content/uploads/2020/10/Ozone-therapyW-218x150.jpg "Stopping neurodegeneration in its tracks with ozone therapy")
